Eisai
4523.T
#2316
Rank
S$10.80 B
Marketcap
S$38.32
Share price
0.77%
Change (1 day)
4.72%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): S$1.14

According to Eisai's latest financial reports the company's current EPS (TTM) is S$1.10. an increase over its 2024 EPS that were of S$1.24.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025S$1.3811.85%
2024S$1.24-32.63%
2023S$1.845.52%
2022S$1.74-74.01%
2021S$6.70-66.58%
2020S$20.0498.24%
2019S$10.1117.01%
2018S$8.6437.78%
2017S$6.27-27.62%
2016S$8.6635.33%
2015S$6.40-2.82%
2014S$6.59-27.66%
2013S$9.11-27.49%
2012S$12.56-12.67%
2011S$14.3888.08%
2010S$7.65-11.06%
2009S$8.60-390.15%
2008S-$2.96-127.78%
2007S$10.6711.78%
2006S$9.544.38%
2005S$9.147.4%
2004S$8.5243.03%
2003S$5.9525.09%
2002S$4.7652.67%
2001S$3.1269.76%
2000S$1.84